Cooley advised Angion on the deal. Angion, a clinical-stage biopharmaceutical company, announced its definitive merger agreement with Elicio Therapeutics. Elicio will merge with a wholly owned subsidiary...
Angion’s Merger Agreement with Elicio Therapeutics
Avant’s $250 Million Financing from Ares
Cooley advised Avant on the deal. Avant, a credit-first financial technology company, announced that it secured $250 million of corporate debt and redeemable preferred equity from...